Press release
Peptide Based Hematological Disorders Therapeutics Market 2017-2022: Hospital Pharmacies Segment to exhibit a CAGR of 7.4% During the Assessment Period
Fact.MR
Request for Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=189
As per the forecast of Fact.MR, the retail pharmacies segment will reach a value of nearly US$ 115 Mn in the year 2017. This represents a robust CAGR growth during the forecast period. The retail pharmacies segment is estimated to account for more than one-third of the revenue share of the distribution channel segment in the year 2017 end and is expected to gain market share by the end of the year 2022.
Icatibant Segment Poised to Touch a Value of Nearly US$ 410 Mn in 2022
As per the forecast of Fact.MR, the icatibant segment is expected to reach a value of nearly US$ 410 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022. Icatibant segment is expected to account for more than three-fourth of the revenue share of the drug segment by the year 2017 and is expected to lose market share by the end of the year 2022.
Hospital Pharmacies Segment to exhibit a CAGR of 7.4% During the Assessment Period
As per the forecast of Fact.MR, the hospital pharmacies segment is slated to touch a figure of nearly US$ 260 Mn in the year 2022. This represents a CAGR of 7.4% during the assessment period from 2017 till the year 2022. This segment is expected to lose market share by the end of the year 2022. The hospital pharmacies segment is expected to account for more than half of the revenue share of the distribution channel segment by the year 2017.
Browse Full Report with TOC- https://www.factmr.com/report/189/peptide-based-hematological-disorders-therapeutics-market
Table of Content:
1. Global Peptide Based Hematological Disorders Therapeutics Market - Executive Summary
2. Global Peptide Based Hematological Disorders Therapeutics Market Overview
2.1. Introduction
2.1.1. Global Peptide Based Hematological Disorders Therapeutics Market Taxonomy
2.1.2. Global Peptide Based Hematological Disorders Therapeutics Market Definition
2.2. Global Peptide Based Hematological Disorders Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Peptide Based Hematological Disorders Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Hematological Disorders Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region
3. Global Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast By Drug
3.1. Global Peptide Based Hematological Disorders Therapeutics Market Size and Forecast By Drug, 2012-2022
3.1.1. Icatibant Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. Ecallantide Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region
Continued….
Request Discount on This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=189
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Based Hematological Disorders Therapeutics Market 2017-2022: Hospital Pharmacies Segment to exhibit a CAGR of 7.4% During the Assessment Period here
News-ID: 971951 • Views: …
More Releases from Fact.MR
USA Solar Light Towers Industry Outlook 2025-2035: Innovation, Growth, and Deman …
The U.S. market for solar light towers-portable, off-grid, solar-powered lighting systems-is entering a phase of strong, sustained growth. Industries such as construction, infrastructure development, event management, emergency response, mining, and remote industrial operations are increasingly shifting toward solar-based lighting solutions due to their lower operating costs, zero emissions, quiet operation, and minimal maintenance requirements.
With growing emphasis on sustainability and operational efficiency, solar light towers are steadily replacing traditional diesel-powered units…
UK Cancer and Tumor Biomarker-based Assay Industry Outlook 2025-2035: Key Develo …
Cancer and tumor biomarker-based assays are analytical tests that detect biological markers associated with cancer presence, progression, recurrence risk, prognosis, and treatment response. These assays play a crucial role in early diagnosis, precision medicine, therapy selection, monitoring minimal residual disease, and assessing recurrence, making them indispensable in modern oncology care.
In the United Kingdom, demand for biomarker-based assays is growing strongly due to rising cancer incidence, expanding adoption of personalized medicine,…
UK Bleaching Clay Industry Forecast 2025-2035: Trends and Growth Insights
Bleaching clay - also called decolorizing clay or activated clay - is a specialty mineral used primarily in the refining and purification of edible oils, fats, waxes, and various industrial liquids. It is valued for its high surface area and adsorption properties, which allow it to remove color bodies, impurities, trace metals, oxidation products, and other undesired components. In the United Kingdom, demand for bleaching clay is closely linked to…
UK Veterinary Dietary Supplements Industry Outlook 2025-2035: Key Developments a …
The UK market for veterinary dietary supplements is experiencing strong growth as pet owners become increasingly health-conscious and veterinarians emphasize preventive wellness. Rising adoption of premium pet foods, growing awareness about joint health, immunity, digestive support, and the overall humanization of pets continue to fuel demand. Supplements formulated for dogs, cats, and production animals are becoming mainstream, supported by innovations in clean-label ingredients and species-specific nutrition.
Quick Stats (2025-2035)
2025 Market Value:…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
